| 000 | 01796 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515195745.0 | ||
| 264 | 0 | _c20100701 | |
| 008 | 201007s 0 0 eng d | ||
| 022 | _a1528-8447 | ||
| 024 | 7 |
_a10.1016/j.jpain.2009.08.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDina, Olayinka A | |
| 245 | 0 | 0 |
_aMechanisms mediating vibration-induced chronic musculoskeletal pain analyzed in the rat. _h[electronic resource] |
| 260 |
_bThe journal of pain _cApr 2010 |
||
| 300 |
_a369-77 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aHindlimb _xdrug effects |
| 650 | 0 | 4 |
_aHyperalgesia _xetiology |
| 650 | 0 | 4 |
_aInflammation _xetiology |
| 650 | 0 | 4 |
_aInflammation Mediators _xpharmacology |
| 650 | 0 | 4 | _aInjections, Spinal |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xdrug effects |
| 650 | 0 | 4 |
_aMusculoskeletal Diseases _xetiology |
| 650 | 0 | 4 |
_aOccupational Exposure _xadverse effects |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xpharmacology |
| 650 | 0 | 4 |
_aPain _xetiology |
| 650 | 0 | 4 |
_aPain Threshold _xphysiology |
| 650 | 0 | 4 |
_aProtein Kinase C-epsilon _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor, Type I _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSecond Messenger Systems _xdrug effects |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
| 650 | 0 | 4 |
_aVibration _xadverse effects |
| 700 | 1 | _aJoseph, Elizabeth K | |
| 700 | 1 | _aLevine, Jon D | |
| 700 | 1 | _aGreen, Paul G | |
| 773 | 0 |
_tThe journal of pain _gvol. 11 _gno. 4 _gp. 369-77 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jpain.2009.08.007 _zAvailable from publisher's website |
| 999 |
_c19345186 _d19345186 |
||